Psychometric Validation of the Kazakh Version of the Patient Health Questionnaire-9 (PHQ-9)
Authors:
- Nursultan SeksenbayevNSNursultan Seksenbayev
- Timur MoldagaliyevTMTimur Moldagaliyev
- Lazzat ZhamaliyevaLZLazzat Zhamaliyeva
- Akmaral BaspakovaABAkmaral Baspakova
- Assel BaibussinovaABAssel Baibussinova
- Nabi YessimovNYNabi Yessimov
- Kamila AkkuzinovaKAKamila Akkuzinova
- Yelaman ToleuovYTYelaman Toleuov
- Shynargul ZhakiyevaSZShynargul Zhakiyeva
- Sandugash KudaibergenovaSandugash Kudaibergenova
- Ken InoueKIKen Inoue
Open Access
- 25 August 2026
- journal article
- research article
- Published by MDPI AG in Healthcare
- Vol. 14 (17) , 2713
Abstract
Background: Depression is a major global health burden, requiring culturally appropriate assessment instruments, but no validated Kazakh-language version of the Patient Health Questionnaire-9 (PHQ-9) is available. This study aimed to translate, culturally adapt, and evaluate the psychometric properties of the Kazakh PHQ-9 in a community-based, non-clinical sample. Methods: This cross-sectional study included 503 Kazakh-speaking adults (mean age = 24.0 years, SD = 10.1; 51.3% women and 48.7% men) who completed the Kazakh PHQ-9 and Generalized Anxiety Disorder-7 (GAD-7) questionnaires. Internal consistency, structural validity, measurement invariance across genders, and convergent validity were assessed. Results: Internal consistency was excellent (Cronbach’s α = 0.91), and both one-factor and correlated two-factor models showed excellent fit (CFI = 0.998; TLI = 0.997–0.998; RMSEA = 0.046–0.048; SRMR = 0.050–0.052), with a slightly better fit for the latter. Measurement invariance across genders was supported, and PHQ-9 and GAD-7 scores were strongly correlated (r = 0.68, p < 0.001). Conclusions: The Kazakh PHQ-9 demonstrated excellent internal consistency and structural validity, measurement invariance across genders, and strong convergent validity in this non-clinical sample. These findings support its use for assessing depressive symptoms in Kazakh-speaking adults. Clinical validation is needed to establish diagnostic validity and screening performance.Keywords
Funding Information
- Ministry of Science and Higher Education of the Republic of Kazakhstan (BR24993083)
This publication has 26 references indexed in Scilit:
- Screening for depression in primary care with Patient Health Questionnaire-9 (PHQ-9): A systematic reviewJournal of Affective Disorders, 2021
- Measurement invariance of the patient health questionnaire‐9 (PHQ‐9) depression screener in U.S. adults across sex, race/ethnicity, and education level: NHANES 2005–2016Depression and Anxiety, 2019
- Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016The Lancet, 2017
- Reliability and validity of the Chinese version of the Patient Health Questionnaire (PHQ-9) in the general populationGeneral Hospital Psychiatry, 2014
- The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic reviewGeneral Hospital Psychiatry, 2010
- Factor structure of the PHQ-9 screen for depression across time since injury among persons with spinal cord injury.Rehabilitation Psychology, 2008
- Comparing the BDI-II and the PHQ-9 with outpatient substance abusersAddictive Behaviors, 2008
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of internal medicine (1960), 2006
- Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9)Journal of Affective Disorders, 2004
- Translating TestsEuropean Psychologist, 1996